ICI therapycheckpoint inhibitionnivolumabsunitinibpembrolizumab
…rich TLS niches.Characterisation of transcriptomic evolution on ICI therapy in ICI-responsive and ICI-resistant primary RCC tumours To unde…
1articles mentioning treatments
2treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: checkpoint inhibition ×
checkpoint inhibition
This treatment is selected. Its supporting articles are shown below.